136 related articles for article (PubMed ID: 37865284)
1. Transcriptome analysis reveals involvement of thiopurine S-methyltransferase in oxidation-reduction processes.
Šmid A; Štajdohar M; Milek M; Urbančič D; Karas Kuželički N; Tamm R; Metspalu A; Mlinarič-Raščan I
Eur J Pharm Sci; 2024 Jan; 192():106616. PubMed ID: 37865284
[TBL] [Abstract][Full Text] [Related]
2. Determination of Thiopurine S-Methyltransferase (TPMT) Activity in Human Erythrocytes by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Li L; Atkinson N; Crews KR; Molinelli AR
Methods Mol Biol; 2024; 2737():465-472. PubMed ID: 38036847
[TBL] [Abstract][Full Text] [Related]
3. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.
Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I
Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339
[TBL] [Abstract][Full Text] [Related]
4. Post-translational stabilization of thiopurine S-methyltransferase by S-adenosyl-L-methionine reveals regulation of TPMT*1 and *3C allozymes.
Milek M; Smid A; Tamm R; Kuzelicki NK; Metspalu A; Mlinaric-Rascan I
Biochem Pharmacol; 2012 Apr; 83(7):969-76. PubMed ID: 22274639
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a UPLC-UV method for the quantification of thiopurine methyltransferase enzyme activity in human erythrocytes.
Illamola SM; Echaabi AK; Mazeron C; Deshayes S; Loriot MA; Pallet N
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1113():91-97. PubMed ID: 30901734
[TBL] [Abstract][Full Text] [Related]
6. No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease.
Lindqvist M; Hindorf U; Almer S; Söderkvist P; Ström M; Hjortswang H; Peterson C
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1033-7. PubMed ID: 17065060
[TBL] [Abstract][Full Text] [Related]
7. Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population.
Klemetsdal B; Straume B; Wist E; Aarbakke J
Eur J Clin Pharmacol; 1993; 44(2):147-52. PubMed ID: 8453958
[TBL] [Abstract][Full Text] [Related]
8. From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity.
Karas-Kuželički N; Šmid A; Tamm R; Metspalu A; Mlinarič-Raščan I
Pharmacogenomics; 2014 Aug; 15(11):1437-49. PubMed ID: 25303295
[TBL] [Abstract][Full Text] [Related]
9. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity.
Lennard L; Welch JC; Lilleyman JS
Br J Clin Pharmacol; 1997 Nov; 44(5):455-61. PubMed ID: 9384462
[TBL] [Abstract][Full Text] [Related]
10. Thiopurine S-methyltransferase activity in Japanese subjects: metabolic activity of 6-mercaptopurine 6-methylation in different TPMT genotypes.
Nishida A; Kubota T; Yamada Y; Higashi K; Kitamura K; Nakahara K; Iga T
Clin Chim Acta; 2002 Sep; 323(1-2):147-50. PubMed ID: 12135816
[TBL] [Abstract][Full Text] [Related]
11. Validation of a high-performance liquid chromatography method for thiopurine S-methyltransferase activity in whole blood using 6-mercaptopurine as substrate.
Rieger H; Schmidt P; Schaeffeler E; Abe M; Schiffhauer M; Schwab M; von Ahsen N; Zurek G; Kirchherr H; Shipkova M; Wieland E
Clin Chem Lab Med; 2018 Apr; 56(5):803-809. PubMed ID: 29194039
[TBL] [Abstract][Full Text] [Related]
12. Purine substrates for human thiopurine methyltransferase.
Deininger M; Szumlanski CL; Otterness DM; Van Loon J; Ferber W; Weinshilboum RM
Biochem Pharmacol; 1994 Nov; 48(11):2135-8. PubMed ID: 7802704
[TBL] [Abstract][Full Text] [Related]
13. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians.
Tai HL; Krynetski EY; Yates CR; Loennechen T; Fessing MY; Krynetskaia NF; Evans WE
Am J Hum Genet; 1996 Apr; 58(4):694-702. PubMed ID: 8644731
[TBL] [Abstract][Full Text] [Related]
14. Association between TPMT*3C and decreased thiopurine S-methyltransferase activity in patients with neuromyelitis optica spectrum disorders in China.
Gong X; Mei S; Li X; Li X; Zhou H; Liu Y; Zhou A; Yang L; Zhao Z; Zhang X
Int J Neurosci; 2018 Jun; 128(6):549-553. PubMed ID: 29191122
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of thiopurine methyltransferase--optimization of drug dosage and potential drug interactions.
Lennard L
Ther Drug Monit; 1998 Oct; 20(5):527-31. PubMed ID: 9780130
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population.
Milek M; Murn J; Jaksic Z; Lukac Bajalo J; Jazbec J; Mlinaric Rascan I
Pharmacology; 2006; 77(3):105-14. PubMed ID: 16691038
[TBL] [Abstract][Full Text] [Related]
17. Assessment of thiopurine S-methyltransferase activity in patients prescribed thiopurines: a systematic review.
Booth RA; Ansari MT; Loit E; Tricco AC; Weeks L; Doucette S; Skidmore B; Sears M; Sy R; Karsh J
Ann Intern Med; 2011 Jun; 154(12):814-23, W-295-8. PubMed ID: 21690596
[TBL] [Abstract][Full Text] [Related]
18. Consequences of binding an S-adenosylmethionine analogue on the structure and dynamics of the thiopurine methyltransferase protein backbone.
Scheuermann TH; Keeler C; Hodsdon ME
Biochemistry; 2004 Sep; 43(38):12198-209. PubMed ID: 15379558
[TBL] [Abstract][Full Text] [Related]
19. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
[TBL] [Abstract][Full Text] [Related]
20. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.
Weinshilboum RM; Sladek SL
Am J Hum Genet; 1980 Sep; 32(5):651-62. PubMed ID: 7191632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
